Skip to main navigation Skip to search Skip to main content

NOD1 and NOD2 expression and function in very preterm infant mononuclear cells

  • Caitlyn Granland
  • , Tobias Strunk
  • , Julie Hibbert
  • , Amy Prosser
  • , Karen Simmer
  • , David Burgner
  • , Peter Richmond
  • , Andrew J. Currie

Research output: Contribution to journalArticleResearchpeer-review

Abstract

RESULTS: NOD1 and NOD2 were expressed by a range of infant and adult mononuclear cell types, including T- and B cells, with highest expression in classical (CD14(++) CD16(-) ) and intermediate (CD14(++) CD16(+) ) monocytes. NOD1 and NOD2 expression levels by monocytes from very preterm infant were similar to those in term infants or adults. Monocyte production of TNFα, IL-6 and IL-1β induced by activation of NOD1 and NOD2 was similar between very preterm infants, term infants and adults.

CONCLUSION: Monocyte expression and function of NOD1 and NOD2 in very preterm infants are intact and comparable/equivalent to term infants and adults. Functional deficiencies in monocyte NOD signalling pathways are unlikely to contribute to the increased susceptibility to bacterial sepsis in preterm infants.

AIM: To evaluate mononuclear cell expression and function of the cytosolic nucleotide-binding oligomerization domain-containing receptors, NOD1 and NOD2, in very preterm and full-term infants.

METHODS: NOD1 and NOD2 gene and protein expression in very preterm infants, term infants and healthy adult, cord and peripheral blood mononuclear cells (C/PBMC) were quantified using qPCR and flow cytometry. Cytokine responses of purified infant and adult monocytes to NOD1- and NOD2-specific agonists were assessed using a multiplex immunoassay (Bioplex).

Original languageEnglish
Pages (from-to)e212-e218
Number of pages7
JournalActa Paediatrica
Volume103
Issue number5
DOIs
Publication statusPublished - May 2014
Externally publishedYes

Keywords

  • Innate immunity
  • Monocyte
  • NOD1
  • NOD2
  • Preterm infant

Cite this